$TORNTPHARM yes, revenue declined QoQ but such events happened on the way of Torrent growth - look at Q4 2012, Q4 2011, Q4 2010, Q2 2009. And it always rebounded to continue 19-30% revenue growth I mentioned before. So don't panic and #hold If the price goes lower - it will be a good buying opportunity!
Rajesh Khattar 09:51 PM 30-01-2015
$TORNTPHARM results are quite disappointing - revenue and gross profit declined. And the revenue in Q1-Q3 2014 is still below that of in Q4 2013. It looks like it's not a growing company any more... #sell while the price is still good
$TORNTPHARM Torrent Pharma announces Q3 FY 14-15 results
• For Q314-15 revenues were at Rs. 1,168 crores, up by 15% from Rs. 1,015 crores during the same period last year.
• EBITDA for Q314-15 was at Rs. 305 crores up by 36% from Rs. 225 crores during the same period last year.
• PAT for Q314-15 was at Rs. 167 crores up by 6% compared to Rs. 158 crores during the same period last year.
• Company declared an interim dividend of 100% (Rs. 5/- per share).
Nita Bhardwaj 12:14 PM 15-01-2015
$TORNTPHARM the company was growing 19-30% in 2012-2014FY and is forecated to grow 15-20% in 2015-2017FY. EBITDA margin was expanding and have reached 27%. It's expected to drop a bit to 25%. And for this growth minus EBITDA decrease you pay 19x EV/EBITDA - for me it's a fair price and I don't expect much growth in the first half of 2015.
Nita Bhardwaj 07:15 PM 09-01-2015
$TORNTPHARM But I expect 7-10% growth in the 2nd half 2015 in line with revenue growth. #hold
Aaarti Ambani 08:05 PM 29-11-2014
$TORNTPHARM@Akshay-Bhardwaj@Rajesh-Khattar I would add that their revenue base is international and well diversified (29% US, 35% Europe, 20% Brasil) so that's why it had steady growth which is not supposed to interrupt. Also, pharma industry is growing well in developed countries - population is aging and wants more drugs unfortunatelly... Torrent is a beneficiary of this process
Akshay Bhardwaj 03:12 PM 29-11-2014
$TORNTPHARM@Rajesh-Khattar this company has a clear long term growth strategy which will keep delivering Revenue and EBITDA growth in 2015. The stock will continue to grow in 2015 - you will see!
Rajesh Khattar 04:42 PM 28-11-2014
$TORNTPHARM is growing since 2015 without major interruption... I believe 2015 will be year for at least a temporary break #hold
Torrent Pharmaceuticals Limited, together with its subsidiaries, manufactures and sells branded and unbranded generic pharmaceutical products in India and internationally. The company offers its products in therapeutic areas of cardiovascular, central nervous system, gastrointestinal, anti-infective, diabetology, and pain management areas. It offers products in the form of tablets, capsules, and parenterals. The company